Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
03 Jun, 2026, 02.36 PM IST
Could space-grown stem cells unlock faster cancer treatments and revolutionize organ regeneration breakthroughs? NASA’s ISS experiments are revealing surprising answers about the power of microgravity medicineSpace stem cell research is rapidly changing cancer treatment and regenerative medicine worldwide. Scientists aboard the International Spac...
29 May, 2026, 08.46 PM IST
Cipla is aiming for 40-50 global product filings in three years, says MD Achin GuptaCipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...
29 May, 2026, 05.30 AM IST
Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEOAs Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...
29 May, 2026, 12.57 AM IST
Scientists say this simple thing may reverse brain aging and restore memory in weeksScientists have developed an experimental nasal spray that shows promise in reversing brain aging. This treatment targets chronic inflammat...
27 May, 2026, 02.21 AM IST
Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
10 May, 2026, 08.50 AM IST
India should chart own path in treatment of rare diseases: ICMR chiefIndia is taking a groundbreaking step forward in the realm of rare disease care with a distinctive approach that champions local ingenuity ...
05 May, 2026, 03.43 PM IST
Sun Pharma looks to outshine rival bids with $13 billion Organon offerSun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...
24 Apr, 2026, 08.17 AM IST
Eyestem’s Eyecyte-RPE trial shows vision rescue for geographic atrophy patientsEyestem will be presenting its data at the ARVO 2025 Annual Meeting as well as the 10th Retinal Cell and Gene Therapy Innovation Summit in ...
14 Apr, 2025, 11.48 AM IST
Indian biotech firm develops world’s first, indigenous Bi-Specific 3rd generation CAR T cells for cancer treatmentThis therapy targets multiple tumor-specific antigens, offering improved treatment precision for blood cancer patients, and significantly r...
18 Mar, 2025, 04.22 PM IST
Ajay Hinduja on advancing cancer care: Insights on CAR-T therapy innovationIndia has reached a milestone in cancer treatment with the first successful allogeneic CAR-T therapy at P. D. Hinduja Hospital, led by Dr. ...
15 Jan, 2025, 04.53 PM IST
Driving innovation: India's foray into gene and cell therapiesIndia is progressing in cell and gene therapy. Research includes treatments for leukemia, hemophilia-A, sickle-cell anemia, and more.
27 Dec, 2024, 11.04 AM IST
East Ocyon Bio closes $4.2M Seed round led by Aeravti Ventures and Micro LabsEast Ocyon Bio aims to reshape India’s role in the global biotech landscape, creating an ecosystem where pioneering therapies are developed...
11 Dec, 2024, 02.11 PM IST
Chinese scientists develop cure for diabetes, insulin patient becomes medicine-free in just 3 monthsChinese scientists achieve diabetes cure through innovative cell therapy, detailed in Cell Discovery. Patient, treated in July 2021, no lon...
27 May, 2024, 04.58 PM IST
A clear policy in stem cell therapy will foster innovative healthcareIndia has the potential to become a leading global player for stem cell products and services. So, the government must act fast in implemen...
27 Dec, 2012, 05.26 AM IST
- Doctors aiming to treat cancer with patients' body cells
Cancer patients can now hope for a new mode of treatment using their own body cells which will do away with side-effect prone conventional ...
06 Apr, 2012, 07.46 PM IST
- DCGI gives approval to Stempeutics Research
The drug controller general of India (DCGI) has given approval to Stempeutics Research, a Manipal Group company, for conducting clinical tr...
25 Mar, 2009, 07.19 PM IST